Send this to a friend

Worcester biotech to treat bubble boy disease

The Worcester facility of New York biotech Mustang Bio will play a role in a new exclusive partnership with a leading children’s medical center to help develop treatments for an immunodeficiency disorder.
Mustang Bio, a subsidiary of Fortress Biotech, said Monday it has entered into an agreement with St. Jude’s Children’s Research Hospital in Tennessee to develop gene therapy treatments for X-linked severe combined immunodeficienc ...

Fields marked in red are required
Your name
Your email
Recipient addresses
(Separate multiple addresses with commas)

Personal message

Copyright 2017 New England Business Media